Lithium and quetiapine augmentation therapy in treatment-resistant depression with atypical features.
Up to 50% of patients with depression do not adequately respond to standard antidepressant therapy, resulting in treatment-resistant depression (TRD), for which lithium and quetiapine are common augmentation strategies. Atypical depression, characterised by mood reactivity and reversed neurovegetative symptoms, is a cl...